ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Praxis Precision Medicines Inc

Praxis Precision Medicines Inc (PRAX)

59.20
-2.98
(-4.79%)
Closed March 27 04:00PM
59.20
0.00
( 0.00% )
Pre Market: 07:06AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
59.20
Bid
57.12
Ask
60.52
Volume
43
0.00 Day's Range 0.00
11.85 52 Week Range 67.21
Market Cap
Previous Close
59.20
Open
-
Last Trade
5
@
59.25
Last Trade Time
05:10:16
Financial Volume
-
VWAP
-
Average Volume (3m)
187,110
Shares Outstanding
13,238,349
Dividend Yield
-
PE Ratio
-6.36
Earnings Per Share (EPS)
-9.31
Revenue
2.45M
Net Profit
-123.28M

About Praxis Precision Medicines Inc

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, fo... Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Praxis Precision Medicines Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRAX. The last closing price for Praxis Precision Medicines was $59.20. Over the last year, Praxis Precision Medicines shares have traded in a share price range of $ 11.85 to $ 67.21.

Praxis Precision Medicines currently has 13,238,349 shares outstanding. The market capitalization of Praxis Precision Medicines is $783.71 million. Praxis Precision Medicines has a price to earnings ratio (PE ratio) of -6.36.

PRAX Latest News

Form S-3 - Registration statement under Securities Act of 1933

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on March 5, 2024 Registration No. 333-      ​ ​...

Form S-8 - Securities to be offered to employees in employee benefit plans

  As filed with the Securities and Exchange Commission on March 5, 2024   Registration No. 333-     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Form 8-K - Current report

FALSE000168954800016895482024-03-052024-03-05 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d)of the...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

false2023FY00016895480.06670.06670.06670.06670.0667http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpensehttp://fasb.org/us-gaap/2023#GeneralAndAdministrativeExpense00016895482023-01-012023-12...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G/A   Under the Securities Exchange Act of 1934 (Amendment No...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.065.4506590666256.1467.2150.2530965658.91031531CS
411.724.631578947447.567.2145.23517808156.55558452CS
1235.46149.36815501323.7467.2123.5418711045.36142211CS
2636.7163.11111111122.567.2113.00533125026.68857149CS
5245.5665334.22452048313.633567.2111.8565428019.903938CS
156-405.8-87.2688172043465512.711.8578208863.59415373CS
260-348.95-85.4955286047408.15914.257511.8571089086.40872286CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 18.12
(281.47%)
602.69k
BCGBinah Capital Group Inc
$ 18.85
(98.42%)
150k
PIKKidpik Corporation
$ 5.08
(55.35%)
1.44M
SSKNStrata Skin Sciences Inc
$ 0.66
(48.35%)
2
PEGRProject Energy Reimagined Acquisition Corporation
$ 11.58
(33.72%)
345
WAVDWaveDancer Inc
$ 2.93
(-18.61%)
10
NCNANuCana PLC
$ 0.25
(-18.47%)
45.39k
INOInovio Pharmaceuticals Inc New
$ 10.65
(-18.27%)
99
WETHWetouch Technology Inc
$ 1.85
(-18.14%)
2.04k
SOBRSOBR Safe Inc
$ 0.41
(-18.00%)
1.49k
KTRAKintara Therapeutics Inc
$ 0.1115
(24.58%)
12.01M
AKBAAkebia Therapeutics Inc
$ 2.42
(8.04%)
4.58M
GMDAGamida Cell Ltd
$ 0.052
(-12.16%)
1.89M
CISSC3is Inc
$ 0.0353
(-7.59%)
1.85M
PIKKidpik Corporation
$ 5.08
(55.35%)
1.44M

Your Recent History

Delayed Upgrade Clock